Mari mulakan
ReutersReuters

Gimv Exits Biolam To Its Management Backed By Investors

GIMB

Gimv NV GIMB:

  • EXITS BIOLAM TO ITS MANAGEMENT BACKED BY INVESTORS AFTER A FAST AND SUCCESSFUL GROWTH TRAJECTORY INTO A LEADING FRENCH GROUP OF CLINICAL TESTING LABS

  • TRANSACTION HAS NO SIGNIFICANT IMPACT ON THE NET ASSET VALUE OF GIMV AS OF 30 SEPTEMBER 2022

  • NO FURTHER FINANCIAL DETAILS WILL BE DISCLOSED

Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini